{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:15:56Z","timestamp":1785575756315,"version":"3.56.0"},"reference-count":46,"publisher":"Oceanside Publications Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2024,1,1]]},"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Different recommendations for the classification of nonsteroidal anti-inflammatory drug hypersensitivity reactions (NSHSR) in children have been reported but a shortage still exists.  <jats:bold>Objective:<\/jats:bold> The aim of the present study was to evaluate the\n inclusivity of two European Academy of Allergy and Clinical Immunology (EAACI) position paper classifications and to characterize the factors that underlie classification discordance in children.  <jats:bold>Methods:<\/jats:bold> Patients with a history of NSHSR were evaluated with a standardized\n diagnostic protocol according to EAACI\/ European Network for Drug Allergy (ENDA) recommendations. Children were classified and compared according to the EAACI 2013 and the pediatric EAACI\/ENDA 2018 classifications. Subjects who were unclassified and those who were classified were compared.\n  <jats:bold>Results:<\/jats:bold> Of 232 patients (median [interquartile range] age 6 years (4\u201011 years) with a history of NSHSR, 52 (22.4%) were confirmed with diagnostic tests. Thirty-six (69.2%) were classified as having cross-intolerance, whereas 16 patients (30.8%) were classified as selective\n responders. Eleven of the confirmed cases (21.2%) could not be categorized according to the 2013 EAACI classification, whereas this number was six adolescents (11.5%) when the 2018 EAACI\/ENDA pediatric classification was used. Patients who were unclassified and who were all cross-intolerant\n were more likely to have atopic sensitization (p = 0.001) and asthma as an underlying disease (p = 0.03), higher serum eosinophil count (p = 0.022), and total immunoglobulin E levels (p = 0.007) compared with those who fit well into the classification. In multivariate regression analysis,\n the presence of atopic sensitization (adjusted odds ratio 20.36 [95% confidence interval, 2.14\u2010193.48]; p = 0.009) was found to be the only significant underlying factor for an unclassified and\/or blended phenotype.  <jats:bold>Conclusion:<\/jats:bold> The 2013 EAACI classification resulted\n in a high rate of subjects who were unclassified. Despite better clinical utility, the recent pediatric EAACI\/ENDA classification system still has shortcomings in terms of inclusivity for adolescents. Mostly, children with underlying allergic diseases could not be classified by the current\n guidelines. We propose to classify them as a separate pediatric cross-intolerance subgroup because the underlying mechanism may involve more than cyclooxygenase 1 inhibition.<\/jats:p>","DOI":"10.2500\/aap.2024.45.230081","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T04:39:42Z","timestamp":1703738382000},"page":"14-23","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of different protocols for classification of pediatric hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: Children with underlying allergic disease should be a separate subgroup"],"prefix":"10.2500","volume":"45","author":[{"given":"Tugba","family":"Arikoglu","sequence":"first","affiliation":[{"name":"From the Department of Pediatric Allergy and Immunology, Faculty of Medicine, Mersin University, Mersin, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazan","family":"Tokmeci","sequence":"additional","affiliation":[{"name":"Department of Pediatric Allergy and Immunology, Ad\u0131yaman University Training and Research Hospital, Ad\u0131yaman, Turkey, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Demirhan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Allergy and Immunology, Mersin City Training and Research Hospital, Mersin, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylin","family":"Kont Ozhan","sequence":"additional","affiliation":[{"name":"From the Department of Pediatric Allergy and Immunology, Faculty of Medicine, Mersin University, Mersin, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysu Ilhan","family":"Yalaki","sequence":"additional","affiliation":[{"name":"From the Department of Pediatric Allergy and Immunology, Faculty of Medicine, Mersin University, Mersin, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veysi","family":"Akbey","sequence":"additional","affiliation":[{"name":"From the Department of Pediatric Allergy and Immunology, Faculty of Medicine, Mersin University, Mersin, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semanur","family":"Kuyucu","sequence":"additional","affiliation":[{"name":"From the Department of Pediatric Allergy and Immunology, Faculty of Medicine, Mersin University, Mersin, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1355","reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jaip.2019.10.049","article-title":"A multicenter retrospective study on hypersensitivity reactions to nonsteroidal anti-\u0131nflammatory drugs (NSAIDs) in children: a report from the European Network on Drug Allergy (ENDA) Group","volume":"8","author":"Mori","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/pai.12980","article-title":"Characteristics of NSAID-induced hypersensitivity reactions in childhood","volume":"30","author":"Cavkaytar","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"key":"B3","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2147\/JAA.S267005","article-title":"NSAID hypersensitivity in the pediatric population: classification and diagnostic strategies","volume":"15","author":"Cavkaytar","year":"2022","journal-title":"J Asthma Allergy"},{"key":"B4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.iac.2014.04.001","article-title":"Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs","volume":"34","author":"Torres","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"B5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/pai.12596","article-title":"Phenotypical characterization of children with hypersensitivity reactions to NSAIDs","volume":"27","author":"Cousin","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"key":"B6","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/all.12260","article-title":"Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs","volume":"68","author":"Kowalski","year":"2013","journal-title":"Allergy"},{"key":"B7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/pai.12915","article-title":"EAACI\/ENDA Position Paper: diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents","volume":"29","author":"Kidon","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"B8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/JAA.S164806","article-title":"NSAID-induced reactions: classification, prevalence, impact, and management strategies","volume":"12","author":"Blanca-Lopez","year":"2019","journal-title":"J Asthma Allergy"},{"key":"B9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.iac.2016.06.001","article-title":"An overview of nonsteroidal antiinflammatory drug reactions","volume":"36","author":"Walters","year":"2016","journal-title":"Immunol Allergy Clin North Am"},{"key":"B10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/all.14032","article-title":"Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs","volume":"75","author":"Do\u00f1a","year":"2020","journal-title":"Allergy"},{"key":"B11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000337660","article-title":"How can we better classify NSAID hypersensitivity reactions?\u2013validation from a large database","volume":"159","author":"Caimmi","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"B12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000438992","article-title":"Different phenotypes of non-steroidal anti-\u0131nflammatory drug hypersensitivity during childhood","volume":"167","author":"Cavkaytar","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"key":"B13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.anai.2020.04.003","article-title":"Results of NSAID provocation tests and difficulties in the classification of children with nonsteroidal anti-inflammatory drug hypersensitivity","volume":"125","author":"Yilmaz Topal","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.alit.2016.10.004","article-title":"Discrepancies in the diagnosis and classification of nonsteroidal anti-inflammatory drug hypersensitivity reactions in children","volume":"66","author":"Arikoglu","year":"2017","journal-title":"Allergol Int"},{"key":"B15","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1034\/j.1398-9995.1999.00247.x","article-title":"Drug hypersensitivity: questionnaire. EAACI interest group on drug hypersensitivity","volume":"54","author":"Demoly","year":"1999","journal-title":"Allergy"},{"key":"B16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.0105-4538.2001.00001.x-i8","article-title":"General considerations for skin test procedures in the diagnosis of drug hypersensitivity","volume":"57","author":"Brockow","year":"2002","journal-title":"Allergy"},{"key":"B17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"key":"B18","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jaip.2017.08.029","article-title":"Acetyl salicylic acid challenge in children with hypersensitivity reactions to nonsteroidal anti-\u0131nflammatory drugs differentiates between cross-\u0131ntolerant and selective responders","volume":"6","author":"Blanca-L\u00f3pez","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/pai.12039","article-title":"Drug provocation tests in the diagnosis of hypersensitivity reactions to non-steroidal anti-inflammatory drugs in children","volume":"24","author":"Zambonino","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"key":"B20","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.2174\/138161208786369731","article-title":"Provocation tests in diagnosing drug hypersensitivity","volume":"14","author":"Bousquet","year":"2008","journal-title":"Curr Pharm Des"},{"key":"B21","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2500\/aap.2015.36.3858","article-title":"Nonsteroidal anti-inflammatory drug hypersensitivity among children","volume":"36","author":"Guvenir","year":"2015","journal-title":"Allergy Asthma Proc"},{"key":"B22","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/all.12266","article-title":"Challenge-proven nonsteroidal anti-inflammatory drug hypersensitivity in children","volume":"68","author":"Yilmaz","year":"2013","journal-title":"Allergy"},{"key":"B23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.anai.2019.07.005","article-title":"Two approaches for diagnosis of nonsteroidal anti-inflammatory drug hypersensitivity in children","volume":"123","author":"Eser Simsek","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B24","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/cea.12140","article-title":"Advanced phenotyping in hypersensitivity drug reactions to NSAIDs","volume":"43","author":"Ayuso","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"B25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1081-1206(10)63146-8","article-title":"Aspirin-induced isolated periorbital angioedema","volume":"81","author":"Quiralte","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1081-1206(10)62748-2","article-title":"Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity","volume":"84","author":"S\u00e1nchez-Borges","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000102614","article-title":"Hypersensitivity to paracetamol in Asian children with early onset of nonsteroidal anti-inflammatory drug allergy","volume":"144","author":"Kidon","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"B28","doi-asserted-by":"crossref","first-page":"e675","DOI":"10.1542\/peds.2005-0969","article-title":"Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children","volume":"116","author":"Kidon","year":"2005","journal-title":"Pediatrics"},{"key":"B29","first-page":"139","article-title":"Increased total and mite-specific immunoglobulin E in patients with aspirin-induced urticaria and angioedema","volume":"20","author":"S\u00e1nchez-Borges","year":"2010","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B30","doi-asserted-by":"crossref","first-page":"16710","DOI":"10.1038\/s41598-018-34668-1","article-title":"NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs","volume":"8","author":"Do\u00f1a","year":"2018","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/all.14119","article-title":"Medical algorithm: diagnosis and treatment of nonsteroidal antiinflammatory drugs hypersensitivity","volume":"75","author":"Dona","year":"2020","journal-title":"Allergy"},{"key":"B32","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1399-3038.2004.00159.x","article-title":"Hypersensitivity to non-steroidal anti-inflammatory drugs in childhood","volume":"15","author":"S\u00e1nchez-Borges","year":"2004","journal-title":"Pediatr Allergy Immunol"},{"key":"B33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2222.2010.03651.x","article-title":"Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response","volume":"41","author":"Do\u00f1a","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"B34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4168\/aair.2021.13.2.171","article-title":"Clinical characteristics of NSAID-induced blended reaction","volume":"13","author":"Hur","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"B35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4168\/aair.2021.13.2.229","article-title":"Clinical characteristics, urinary leukotriene E4 levels, and aspirin desensitization results in patients with NSAID-\u0131nduced blended reactions","volume":"13","author":"Klaewsongkram","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"B36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2332\/allergolint.13-OA-0536","article-title":"Aspirin augments IgE-mediated histamine release from human peripheral basophils via Syk kinase activation","volume":"62","author":"Matsuo","year":"2013","journal-title":"Allergol Int"},{"key":"B37","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.1365-2133.2002.04601.x","article-title":"Food-dependent exercise-induced anaphylaxis: influence of concurrent aspirin administration on skin testing and provocation","volume":"146","author":"Aihara","year":"2002","journal-title":"Br J Dermatol"},{"key":"B38","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.2500\/ar.2012.3.0025","article-title":"Mite-induced inflammation: more than allergy","volume":"3","author":"S\u00e1nchez-Borges","year":"2012","journal-title":"Allergy Rhinol (Providence)"},{"key":"B39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jaci.2006.10.002","article-title":"The A-444C polymorphism of leukotriene C4 synthase gene is associated with IgE antibodies to Dermatophagoides pteronyssinus in a Colombian population","volume":"119","author":"Acevedo","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B40","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jaci.2005.12.1329","article-title":"Leukotriene D4 enhances immunoglobulin production in CD40-activated human B lymphocytes","volume":"117","author":"Lamoureux","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"B41","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/cea.12735","article-title":"Nonsteroidal anti-inflammatory drugs enhance IgE-mediated activation of human basophils in patients with food anaphylaxis dependent on and independent of nonsteroidal anti-inflammatory drugs","volume":"46","author":"Pascal","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"B42","doi-asserted-by":"crossref","first-page":"1071807","DOI":"10.3389\/falgy.2022.1071807","article-title":"Non-steroidal anti-inflammatory drug-induced anaphylaxis infrequent in 388 patients with mastocytosis: a two-center retrospective cohort study","volume":"3","author":"Bonadonna","year":"2022","journal-title":"Front Allergy"},{"key":"B43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1254\/jphs.08R32FM","article-title":"Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: aspirin modulation of IgE-dependent mast cell activation: role of aspirin-induced exacerbation of immediate allergy","volume":"110","author":"Suzuki","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"B44","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jaci.2014.06.004","article-title":"Cyclooxygenase inhibition abrogates aeroallergen-induced immune tolerance by suppressing prostaglandin I2 receptor signaling","volume":"134","author":"Zhou","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B45","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4168\/aair.2020.12.4.712","article-title":"In vitro and \u0131n vivo validation of EP2-receptor agonism to selectively achieve \u0131nhibition of mast cell activity","volume":"12","author":"Plaza","year":"2020","journal-title":"Allergy Asthma Immunol Res"},{"key":"B46","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/cea.12542","article-title":"Activation of the prostaglandin E2 receptor EP2 prevents house dust mite-induced airway hyperresponsiveness and inflammation by restraining mast cells' activity","volume":"45","author":"Serra-Pages","year":"2015","journal-title":"Clin Exp Allergy"}],"container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2024\/00000045\/00000001\/art00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T04:40:26Z","timestamp":1703738426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2024.45.230081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,1]]}},"alternative-id":["1088-5412(20240101)45:1L.14;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2024.45.230081","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,1]]}}}